Physician profile
Asim Sayed
NPI 1801329925
$4,283.71
in general payments reported to CMS, 2019-2025
23 companies · $521 in 2025
The $521 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $937 · 2020: $88.16 · 2021: $132 · 2022: $718 · 2023: $639 · 2024: $1,249 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,999 · Travel and Lodging: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,998.67 |
| Travel and Lodging | $410.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,954.30 | 2022-2025 | Prostep, Augment Injectable, Ortholoc 3di |
| Southern Edge Orthopaedics, INC. | $937.00 | 2019 | |
| Treace Medical Concepts, INC. | $353.47 | 2023-2025 | |
| Kerecis Limited | $198.16 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $164.08 | 2021-2025 | Grafix Pl, Stravix Pl |
| Angiodynamics, INC. | $104.13 | 2022 | |
| Abbvie INC. | $99.22 | 2021-2025 | Dalvance |
| Abbott Laboratories | $76.67 | 2020 | |
| Convatec INC. | $74.94 | 2023-2025 | |
| Nevro Corp. | $45.62 | 2022-2023 | Senza |
| Acumed LLC | $41.93 | 2025 | Acumed |
| Polynovo North America LLC | $24.62 | 2022 | |
| Biocomposites INC | $24.38 | 2025 | Stimulan |
| Averitas Pharma INC. | $24.23 | 2023 | Qutenza |
| Flower Orthopedics Coporation | $23.21 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $21.73 | 2023 | Xperience, Blastx, Surgx |
| Acera Surgical, INC. | $21.37 | 2022 | |
| Titan Surgical Group, LLC | $19.88 | 2023 | |
| Heron Therapeutics, INC. | $16.79 | 2023 | Zynrelef |
| Paratek Pharmaceuticals, INC. | $16.55 | 2021 | |
| Solventum Corporation | $15.24 | 2025 | Prevena |
| Integra Lifesciences Corporation | $14.70 | 2023 | Tenoglide |
| Allergan, INC. | $11.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asim Sayed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.